Ann: US DoD NMRC files IND application with FDA, page-25

"is pleased to announce the appointment of Steven Lydeamore as Chief Executive
Officer (CEO) of the Company effective 27 June 2022"

Can't wait for Steve to start his position as CEO and freshen up the joint and bring new ideas.

Jerry unfortunately seems set in his ways, as when a broker of mine suggested a reputable broker research report last year in a phone call, he scoffed at the suggestion. even though he believed the shareprice should be well north of 30c. well if you got a broker to put that in writing in a concise report and analysis, well Jerry that would be possible. absolute stupido mentality !!